News CSL Limited

Stocks

CSL

AU000000CSL8

Pharmaceuticals

Market Closed - Australian S.E. 02:18:24 2026-09-24 EDT			5-day change	1st Jan Change
179.12 ^AUD	-0.07%		+0.88%	+3.75%

09-22	Csl Canada Expands Public Access to Andembry® Across Canada for the Prevention of Hereditary Angioedema Attacks	CI
09-21	Australian shares end flat as miners offset gains in banks	RE

All News

Mentions Relevance

09-22	Csl Canada Expands Public Access to Andembry® Across Canada for the Prevention of Hereditary Angioedema Attacks	CI
09-22	Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks	AQ
09-16	CSL Acknowledges Shareholder Frustration, Says Company Was Slow in Adapting to Competitive Pressures	MT
09-10	CSL Seqirus Publishes Phase 3 Study Results for Influenza Vaccine	MT
09-10	CSL : Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults	PU
09-03	CSL Says Vanguard Group Raises Stake	MT
08-31	CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing	MT
08-31	CSL : Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing	PU
08-31	Australia's CSL to Lower Medicaid Prices Amid U.S. Expansion	DJ
08-25	CSL Limited announces an Equity Buyback for AUD 1,150 million worth of its shares.	CI
08-25	CSL Limited authorizes a Buyback Plan.	CI
08-18	CSL Limited Provides Earnings Guidance for the Year 2027	CI
08-18	Australia shares end flat as BHP, CSL offset banks' decline	RE
08-18	Csl Limited Announces Dividend for Six Month Ended June 30, 2026, Payable on 2 October 2026	CI
08-18	CSL Expects Flat Revenue for Fiscal 2027 With Return to Profit Growth	MT
08-17	CSL Fiscal 2026 Underlying NPATA Earnings Per Share Down, Revenue Up; Shares Surge 18%	MT
08-17	CSL Limited, 2026 Earnings Call, Aug 18, 2026
08-17	CSL's Fiscal 2026 Results In Line, Jefferies Says	MT
08-17	CSL's Share Price Hits Six-Month High on Guidance Beat	DJ
08-17	BHP, CSL gains help Australian shares snap four-day losing streak	RE
08-17	CSL Fiscal 2026 Underlying NPATA Earnings Per Share Down, Revenue Up	MT
08-17	Australia's CSL surges 18% on earnings beat, upbeat plasma business forecast	RE
08-17	CSL Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
08-17	CSL Swings to $2.58 Billion Annual Loss on Write-Downs	DJ
08-06	CSL Says European Commission Revokes Marketing Authorization for Tavneos	MT